Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.

× No keyword cloud information.

19 in total

1. Radiation protective effect of an extract from Chelidonium majus.

Authors: Jie-Young Song; Hyun-Ok Yang; Ji-Young Shim; Young-Soo Han; In-Sung Jung; Yeon-Sook Yun
Journal: Int J Hematol Date: 2003-10 Impact factor: 2.490

2. Immunomodulatory and therapeutic properties of FK-565 in mice.

Authors: J E Talmadge; B Lenz; M Schneider; H Phillips; C Long
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

3. An assessment of the effects of swainsonine on survival of mice injected with B16-F10 melanoma cells.

Authors: M J Humphries; K Matsumoto; S L White; R J Molyneux; K Olden
Journal: Clin Exp Metastasis Date: 1990 Jan-Feb Impact factor: 5.150

4. Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis.

Authors: H Fukui; C W Reynolds; B Lenz; M Schneider; J E Talmadge
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

5. Assessment of in vitro lymphokine activated killer (LAK) cell activity against renal cancer cell lines and its suppression by serum factor using crystal violet assay.

Authors: H Kanamaru; O Yoshida
Journal: Urol Res Date: 1989

6. Comparison of immunomodulatory and immunotherapeutic properties of biologic response modifiers.

Authors: J E Talmadge; M A Chirigos
Journal: Springer Semin Immunopathol Date: 1985

7. A new sclerosant therapy for testicular hydrocele with aspiration and injection of OK-432.

Authors: M Yamamoto; H Hibi; K Miyake
Journal: Int Urol Nephrol Date: 1994 Impact factor: 2.370

8. The indications for tumor mass reduction surgery and subsequent multidisciplinary treatments in stage IV hepatocellular carcinoma.

Authors: M Yamamoto; H Iizuka; M Matsuda; K Nagahori; K Miura; J Itakura
Journal: Surg Today Date: 1993 Impact factor: 2.549

9. Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy.

Authors: S Yamasaki; N Kan; T Harada; Y Ichinose; Y Moriguchi; L Li; T Sugie; H Kodama; K Satoh; K Ohgaki
Journal: Breast Cancer Res Treat Date: 1993 Impact factor: 4.872

10. Induction of antitumor L3T4-positive T cells by OK-432 at tumor sites in mice.

Authors: Y Moriya; H Sato; K Ito; M Saito; T Yoshida; N Ishida
Journal: Cancer Immunol Immunother Date: 1993 Impact factor: 6.968